The Effects Of Prenatal Health Education On Birth Preparedness And Complication Readiness Among Pregnant Women
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorBule Hora University
About this trial
Study setting: The study will be conducted from May 1 to November 2026 in the West Shewa Zone.
Objectives: To measure the effect of health education on birth preparedness and complication readiness practice among pregnant women in the districts of the West Shewa Zone in 2026 (Stepped Wedge Randomized Controlled Trial) Null hypothesis (H₀): There will be no difference in the proportion of birth preparedness and complication readiness among pregnant women between intervention and control periods.
Alternative Hypothesis (Ha): Health education intervention on BPCR will result in a significant increase in the proportion of well-prepared pregnant women in the intervention periods across all study sites.
The study population will consist of randomly selected pregnant women in selected public health centers in Districts of west shewa zone.
The west shewa zone districts were selected by simple random sampling methods .Ejere, Ejersa Lefo and Holota districts were selected using simple random sampling .Then Five health centers namely Yaya , Olankomi, Gorba ,Ejere and Gilgel kuyu health centers from three districts of west shewa zone were selected.
Will be then randomized to time of crossover (step) using computer-generated sequences. Because of this, the study design involves a sequential rollout where all groups eventually receive the health education intervention aimed at evaluating birth preparedness and complication readiness changes. At the beginning, the five clusters were identified by simple random sampling. Sequential allocation or randomly assigning each cluster to a specific wedge or starting point will be conducted. At the baseline all clusters begin in the control phase. During the steps (every month to six months) one or more clusters cross over to the intervention phase (implementing BPCR education). During the end phases, all clusters are in the intervention group. The study involves cohort sampling; the same pregnant women are followed through the entire study for six months. All eligible pregnant women attending antenatal care during defined periods in each cluster will eventually receive health education.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pregnant women who are in the first trimester of their pregnancy (up to 16 weeks' gestation) and
Pregnant women who have lived in the study area for more than six months will be included.
Disqualifiers
Pregnant women with serious illnesses or those who intend to move during the intervention's execution
Severe conditions requiring intensive hospital follow-up.
Pregnant women who have previously taken part in a similar study elsewhere will not be allowed to join.
Trial design
Design model
Crossover
Treatments tested in this trial
health education intervention on birth preparedness and complication readiness
Other interventionboth arms eventually will take educational interventions
Treatment groups
576 Participants
are divided into 2 treatment groupsGroup A: pregnant women who will take educational interventionExperimental treatment 1 intervention
Group B: pregnant women who will receive routine health careNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
birth preparedness and complication readiness
If a woman reported that she willprearranges at least two of the five components of birth preparedness and complicationreadiness (willl be assessed by standard pretestedquestionnaires), she will be considered "well prepared forbirth."; But if a pregnant woman reports that she prearranges fewer than two components of birth preparedness and complication readiness, she will be considered "poorly prepared." These five components of birth preparedness and complication readiness are: * Identification of the place of delivery, * saving money, * arranging transport, * identifying a birth companion, and * prearranging a potential blood donor, These are measured by pretested questionnaires.
Time frame
6monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov